Anbio Biotechnology (NNNN) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Anbio Biotechnology (NNNN).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $46.05

Daily Change: +$1.50 / 3.27%

Daily Range: $43.10 - $46.50

Market Cap: $2,021,189,760

Daily Volume: 119,933

Performance Metrics

1 Week: 3.32%

1 Month: -11.12%

3 Months: 605.2%

6 Months: 770.2%

1 Year: 770.2%

YTD: 698.1%

Company Details

Employees: 27

Sector: Health technology

Industry: Medical specialties

Country:

Details

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Selected stocks

Brighthouse Financial, Inc. - Depositary Shares 6.6% Non-Cumulative Preferred Stock, Series A (BHFAP)

Brighthouse Financial, Inc. - Depositary Shares, each representing a 1/1,000th interest in a share of 6.750% Non-Cumulative Preferred Stock, Series B (BHFAO)

Brighthouse Financial, Inc. - depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN)